Article
Unlocking the potential of Tregs: innovations in CAR technology
12 Oct 2023
Abstract excerpt
Regulatory T cells (Tregs) adoptive immunotherapy is emerging as a viable treatment option for both autoimmune and alloimmune diseases. However, numerous challenges remain, including limitations related to cell number, availability of target-specific cells, stability, purity, homing ability, and safety concerns. To address these challenges, cell engineering strategies have emerged as promising solutions. Indeed,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
